Daebonglsco.,Ltd
KOSDAQ-listed pharmaceutical and cosmetic ingredient company developing a GLP-1 analog obesity treatment among its API pipeline.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1986 and listed on KOSDAQ in 2005, Daebong LS is a company specializing in active pharmaceutical ingredients (APIs) and functional cosmetic ingredients. It produces APIs for respiratory, hypertension, and gastrointestinal treatments as well as natural and fusion-synthesized functional cosmetic ingredients, and is co-developing a GLP-1 analog obesity treatment (code-named L) with an Indian CDMO under an NDA and MOU, alongside a nail fungus treatment (E), hypertension treatment (A), and heart failure and peptic ulcer treatments (V). Consolidated revenue for the period grew 8.6% year-over-year to KRW 102.1 billion, and its subsidiary PNK Skin Research Center provides human application testing for cosmetics, beauty devices, and health functional foods.
Products & technology
- APIs (respiratory, hypertension, gastrointestinal treatments)Active pharmaceutical ingredients supplied to domestic drug makers
- Functional cosmetic ingredients (natural and fusion-synthesized)Raw materials for cosmetics
R&D and key agreements
Source: DART corporate disclosureL(비만치료제) · 비만/당뇨 · 인도 CDMO 공동연구, NDA·MOU 체결 · Ionic-liquid and sonochemistry synthesis method patented; global obesity drug market projected to grow from USD 19.037bn (2023) to USD 37.367bn (2028)
L(진해거담제, 개량신약) · 진해거담 · DMF 등록 준비중
A(고혈압치료제) · 고혈압 · 비임상시험 진행중
E(조갑진균치료제) · 조갑진균증 · DMF등록 및 IND신청 준비 · Technology evaluation grade BB
V(심부전치료제) · 심부전 · 제제연구단계
V(위궤양·십이지장궤양치료제) · 위궤양 및 십이지장궤양 · 일본 제약사와 공동개발
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition